Facial Injectables Market Poised to Reach US$ 37.1 Billion by 2031, Driven by Growing Demand for Non-Invasive Procedures and Technological Innovations | TMR

News provided by

Aug 02, 2024, 10:15 ET

Facial injectables are substances that are injected into facial tissues to enhance facial features, reduce wrinkles, restore volume, or improve overall appearance. These substances often provide temporary or semi-permanent effects and are utilized to address signs of aging or achieve specific esthetic goals.

WILMINGTON, Del., Aug. 2, 2024 /PRNewswire/ -- As per Transparency Market Research (TMR), a leading global market research company, rise in cosmetic surgeries across the world is projected to propel the facial injectables market growth at a whopping 12.0% CAGR from 2023 to 2031.

Penetration of Social Media Responsible for Bright Facial Injectables Market Outlook

Facial injectables are commonly used on nasolabial folds, cheekbones, and lips. For instance, dynamic wrinkles caused by different movements are minimized by injecting botulinum toxin, often known as Botox, into the face's muscles.

Rise in popularity of social media is a key factor fostering market expansion. A large percentage of the population that opts for cosmetic procedures that involve facial injectables consults an online source.

This tech savvy population, primarily the younger generation, is often exposed to information regarding such procedures on platforms such as Instagram and Facebook. Additionally, celebrity influencers are driving market progress.

Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1779

Facial Injectables Market Key Insights

Growth in elderly population augmenting market dynamics
Launch of new products by leading players augmenting market statistics

- Robust Demand for Facial Injectables Among Elderly Population Boosting Facial Injectables Market Value

Dermal fillers often consist of hyaluronic acid, polylactic acid, or calcium hydroxylapatite; Botox is a neurotoxic protein. These treatments, which are administered by medical professionals, provide immediate results that usually last a few months to a year.

Growth in the elderly population and increase in popularity of cosmetic operations among the aging people are likely to propel the expansion of the facial injectables landscape.

A recent WHO report stated that one in six people in the world will be aged 60 years or above by 2030. The global population of people aged 60 years and older will double (2.1 billion) by 2050. The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

- Efforts by Key Players to Launch Injectables that Cater to Facial and Body Treatments Augmenting Facial Injectables Market Development

Prominent companies in the global facial injectables market are striving to create sophisticated fillers with enhanced characteristics.

In order to meet the needs and preferences of individual patients, they are introducing injectables with improved qualities, such as improved safety profiles, greater integration with tissues, and longer-lasting benefits.

In July 2024, the U.S. FDA approved a new indication for the anti-wrinkle injectable, which was first introduced in 2011 to treat moderate to severe wrinkles between the glabellar lines. This expansion makes the neurotoxin the only one that can simultaneously treat crow's feet and the upper forehead lines.

Facial Injectables Market Regional Insights

North America was the leading contributor to the market share in 2022. The region is expected to maintain its dominance during the forecast period.

Growth in number of people opting for esthetic procedures to enhance physical appearances, surge in technological advancements, presence of well-established healthcare facilities, and significant presence of advanced medical spas and cosmetic surgery centers are propelling market development in the region.

According to the American Society of Plastic Surgeons, cosmetic surgery procedures rose by 19.0% in 2022 as compared to that in 2019. Procedures related on the body, including liposuction, tummy tuck (abdominoplasty), and arm and lower body lifts dominated, with a 25% rise and 576,485 procedures in total in 2022.

Facial Injectables Market Report Scope:

Report Coverage	Details
Forecast Period	2023-2031
Base Year	2017-2021
Size in 2023	US$ 13.5 Bn
Forecast (Value) in 2034	US$ 37.1 Bn
Growth Rate (CAGR)	12.0 %
No. of Pages	150 Pages
Segments covered	By Product Type, By Application, By Region, By End-user

Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1779

Leading Players in Facial Injectables Industry

Allergan, Inc., Ipsen (Mayroy SA), Merz Pharma, Suneva Medical, Inc., Medytox, Inc., Sinclair Pharma, Bloomage BioTechnology, Anika Therapeutics, Inc., Prollenium Medical Technologies, and Galderma are the prominent companies functioning in the global facial injectables landscape.

Key Strategies Adopted by Facial Injectables Market Players

Prominent players are collaborating with numerous biotech companies, research institutes, and esthetics companies in order to develop cutting-edge injectables.

They are also collaborating strategically with cosmetic surgeons and dermatologists to improve clinical acceptance and develop products based on expert input. Such partnerships are likely to ensure the highest levels of efficacy and safety.

In May 2023, Evolus, Inc. a performance beauty company that focuses on developing an esthetic portfolio, announced that it had signed a definitive agreement with Symatese to serve as the exclusive distributor for four distinct dermal fillers in late-stage development in the U.K. and Europe.

The fillers are expected to receive regulatory clearances in the second half of 2024 and go on sale under the brand name ESTYME Fillers in 2025.

This is the second deal Symatese and the company had reached; the first granted exclusive distribution rights to the same product line in the U.S, where it will be marketed in 2025 under the Evolysse brand.

Facial Injectables Market Segmentation

Product Type

Collagen
Hyaluronic Acid (HA)
Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Polymethylmethacrylate Beads (PMMA Microspheres)
Poly-L-Lactic Acid (PLLA)
Others (Polyalkylimide)

Application

Facial Line Correction
Lip Augmentation
Acne Scar Treatment
Face Lift
Lipoatrophy Treatment
Others (Earlobe Rejuvenation)

End-user

Hospitals
Dermatology Clinics
Others (Beauty Clinics)

Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=1779&ltype=S

More Trending Reports by Transparency Market Research –

Platelet Incubator Market -The global platelet incubator market was valued at US$ 453.7 million in 2022. It is estimated to grow at a CAGR of 4.9% from 2023 to 2031, reaching US$ 703.8 million by the end of 2031.
Next Generation Sequencers (NGS) Market - The next generation sequencers market was valued at US$ 1.2 billion in 2022. It is projected to grow at a CAGR of 8.3% from 2023 to 2031, reaching more than US$ 2.4 billion by the end of 2031.
Spine Surgery Products Market - The spine surgery products market was valued at US$ 13.3 billion in 2022. It is estimated to grow at a CAGR of 4.5% from 2023 to 2031, reaching US$ 20.0 billion by the end of 2031.
Metastatic Bone Disease Market - The metastatic bone disease market was valued at US$ 17.0 billion in 2022. It is estimated to grow at a CAGR of 8.7% from 2023 to 2031, reaching US$ 36.4 billion by the end of 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]
Follow Us: LinkedIn | Twitter | Blog | YouTube